4 reports

  • Executive Summary
  • 4.3 Molecular Targets in the Pipeline

Alexion only markets one product in the gastrointestinal therapy area, namely Soliris.

  • Gastrointestinal Drug
  • Pharmaceutical
  • Therapy
  • Market Size
  • Johnson & Johnson
  • GASTROINTESTINAL DRUGS
  • Global Gastrointestinal Drugs Market, Competitor Market Shares And Revenues, 2017 Company

Pharmaceutical Drugs Global Market Opportunities And Strategies By the Drugs For Treatment: Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs,...

  • Gastrointestinal Drug
  • Healthcare
  • Pharmaceutical
  • Forecast
  • Johnson & Johnson

Safe if provided warnings are followed ##.

  • Gastrointestinal Drug
  • World
  • Market Size
  • AstraZeneca PLC
  • Johnson & Johnson
  • Gastrointestinal Drugs
  • MARKET AND COMPETITIVE ANALYSIS

Over the past 38 years the U.S. Rx-to-OTC market has grown into a $7.8 billion market. This has mainly been due to factors such as patent expirations, increasing competitiveness with the pharmaceutical environment, brand re-invention, consumer demand, and cost containment strategies. The U.S. market for Rx-to-OTC Switches encompasses a wide...

  • Allergy Drug
  • Gastrointestinal Drug
  • OTC
  • United States
  • Johnson & Johnson